Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis

被引：0
|
作者：
R. Lindsay
P. Miller
G. Pohl
E. V. Glass
P. Chen
J. H. Krege
机构：
[1] Helen Hayes Hospital,
[2] University of Colorado Health Sciences Center,undefined
[3] Denver,undefined
[4] and Colorado Center for Bone Research,undefined
[5] Eli Lilly and Company,undefined
[6] Lilly Corporate Center,undefined
来源：
Osteoporosis International | 2009年 / 20卷
关键词：
Back pain; Nonvertebral fracture; Osteoporosis; Parathyroid hormone; Postmenopausal women; Teriparatide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：943 / 948
页数：5
相关论文
共 50 条
  • [1] Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis
    Lindsay, R.
    Miller, P.
    Pohl, G.
    Glass, E. V.
    Chen, P.
    Krege, J. H.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 (06) : 943 - 948
  • [2] COMPARING CLINICAL AND ECONOMIC OUTCOMES OF DENOSUMAB AND TERIPARATIDE MEDICATIONS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Elsalmawy, A. H. E.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S219 - S219
  • [3] Relationship between teriparatide-mediated changes in bmd and microarchitecture in postmenopausal women with osteoporosis
    Recker, R.
    Resch, H.
    Chen, P.
    Misurski, D.
    Pavo, I
    Sipos, A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S211 - S211
  • [4] Relationship between teriparatide-mediated changes in BMD and microarchitecture in postmenopausal women with osteoporosis
    Recker, R.
    Resch, H.
    Chen, P.
    Misurski, D.
    Pavo, I.
    Sipos, A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S75 - S76
  • [5] Occurrence of hypercalciuria with teriparatide therapy in postmenopausal women and in men with osteoporosis
    Miller, Paul D.
    Bilezikian, John P.
    Chen, Peiqi
    Marin, Fernando
    Krege, John
    Wong, Mayme
    Marcus, Robert
    [J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S230 - S230
  • [6] Teriparatide therapy and risk of hypercalciuria in postmenopausal women with osteoporosis.
    Miller, P.
    Bilezikian, J.
    Chen, P.
    Marin, F.
    Krege, J.
    Wong, M.
    Marcus, R.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S299 - S299
  • [7] Postmenopausal women with osteoporosis: experience when treated with teriparatide in clinical practice
    Ish-Shalom, Sophia
    Dumitrache, Constantin
    El-Husseini, Timour Fikry
    Hussein, Azza
    Barker, Clare
    Pavo, Imre
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (02) : 343 - 353
  • [8] COMPARING CLINICAL AND ECONOMIC OUTCOMES OF DENOSUMAB AND TERIPARATIDE MEDICATIONS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS 10 YEARS EXPERIENCE
    Zidan, S. F. Z.
    Elsalmawy, A. H. E.
    Bajuifer, S. J. B.
    Almaimani, W. H. A.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S108 - S109
  • [9] Effects of teriparatide on quality of life in postmenopausal women with osteoporosis
    Rosa, Jan
    Kasalicky, Petr
    Mala, Ivana
    [J]. BONE, 2008, 42 : S85 - S86
  • [10] Review: Teriparatide reduces fractures in postmenopausal women with osteoporosis
    Johnson, Bruce E.
    [J]. ANNALS OF INTERNAL MEDICINE, 2012, 157 (06)
12345